Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
ETON Eton Pharmaceutical
- 12.570
- +0.290+2.36%
Close Dec 20 16:00 ET
- 12.570
- 0.0000.00%
Post 20:01 ET
327.47MMarket Cap-59.86P/E (TTM)
13.290High12.170Low281.56KVolume12.290Open12.280Pre Close3.60MTurnover1.37%Turnover RatioLossP/E (Static)26.05MShares13.98052wk High20.51P/B257.75MFloat Cap3.03052wk Low--Dividend TTM20.51MShs Float13.980Historical High--Div YieldTTM9.12%Amplitude1.950Historical Low12.790Avg Price1Lot Size
About Eton Pharmaceutical Company
Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.
Company Profile
SymbolETON
Company NameEton Pharmaceutical
Listing DateNov 13, 2018
Issue Price6.00
Founded2017
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address21925 West Field Parkway,Suite 235
CityDeer Park
ProvinceIllinois
CountryUnited States of America
Zip Code60010-7278
Phone1-847-787-7361
Websitehttp://www.etonpharma.com
Company Executives
- Name
- Position
- Salary
- Sean E. Brynjelsen
- President, Chief Executive Officer and Director
- 1.75M
- James R. Gruber
- Chief Financial Officer, Principal Accounting Officer, Treasurer and Secretary
- 785.14K
- David C. Krempa
- Chief Business Officer
- 719.08K
- Dr. Norbert G. Riedel,PhD
- Chairman of the Board
- 155.50K
- Paul Victor Maier
- Independent Director
- 129.50K
- Jennifer McKie Adams
- Independent Director
- 119.10K
- Charles J. Casamento
- Independent Director
- 126.90K